| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5723147 | PACIRA PHARMS INC | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
Mar, 2015
(9 years ago) | |
| US5931809 | PACIRA PHARMS INC | Epidural administration of therapeutic compounds with sustained rate of release |
Jul, 2015
(8 years ago) | |
| US5807572 | PACIRA PHARMS INC | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
Sep, 2015
(8 years ago) | |
| US6193998 | PACIRA PHARMS INC | Method for producing liposomes with increased percent of compound encapsulated |
Sep, 2016
(7 years ago) | |
| US6241999 | PACIRA PHARMS INC | Method for producing liposomes with increased percent of compound encapsulated |
Sep, 2016
(7 years ago) | |
| US5997899 | PACIRA PHARMS INC | Method for producing liposomes with increased percent of compound encapsulated |
Sep, 2016
(7 years ago) | |
| US6171613 | PACIRA PHARMS INC | Method for producing liposomes with increased percent of compound encapsulated |
Oct, 2016
(7 years ago) | |
| US5891467 | PACIRA PHARMS INC | Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
Jan, 2017
(7 years ago) | |
| US5962016 | PACIRA PHARMS INC | Multivesicular liposomes utilizing neutral lipids to modify in vivo release |
Jan, 2017
(7 years ago) | |
Depodur is owned by Pacira Pharms Inc.
Depodur contains Morphine Sulfate.
Depodur has a total of 9 drug patents out of which 9 drug patents have expired.
Expired drug patents of Depodur are:
- US5723147
- US5931809
- US5807572
- US6193998
- US6241999
- US5997899
- US6171613
- US5891467
- US5962016
Depodur was authorised for market use on 18 May, 2004.
Depodur is available in injectable, liposomal;epidural dosage forms.
Depodur can be used as single-dose administration by the epidural route, at the lumbar level, for the treatment of pain following major surgery.
The generics of Depodur are possible to be released after 31 January, 2017.
Drugs and Companies using MORPHINE SULFATE ingredient
Market Authorisation Date: 18 May, 2004
Treatment: Single-dose administration by the epidural route, at the lumbar level, for the treatment of pain following major surgery
Dosage: INJECTABLE, LIPOSOMAL;EPIDURAL
DEPODUR family patents
